CONDITION

Intestinal Lymphangiectasia

Intestinal lymphangiectasia is a condition in which the lymphatic vessels inside the wall of the intestine become abnormally widened and dilated. These vessels normally carry protein-rich fluid away from the gut, but when they are dilated or blocked, they leak lymph into the intestinal lumen. The result is that protein, particularly albumin, is lost into the gut and passed out in faeces, rather than being retained in the bloodstream. Owners most often notice soft or watery diarrhoea, gradual weight loss, or a swollen abdomen. In some animals the coat becomes dull or the paws and limbs appear puffy. The condition can develop gradually, or signs may appear more suddenly. It tends to affect middle-aged dogs, though it can occur at any life stage. Certain breeds—including Yorkshire Terriers, Soft Coated Wheaten Terriers, and Norwegian Lundehunds—are seen more frequently, though any dog may be affected. This page explores what an owner might observe, what is happening beneath those signs, how the condition is investigated through blood tests and imaging, and the dietary and medical approaches that exist to support dogs living with intestinal lymphangiectasia.

Why this matters now

Intestinal lymphangiectasia can appear at any age, though case series report a typical onset in middle-aged to older dogs, often between five and nine years old, with some dogs affected earlier or later. Certain breeds—including Yorkshire Terriers, Soft Coated Wheaten Terriers, and Norwegian Lundehunds—appear more frequently in case series, though the condition is reported across many breeds and in mixed-breed dogs. In some animals, the lymphatic abnormality may be present from early life but remain silent until triggered by inflammation, infection, or dietary factors.

The course of the condition varies considerably between individuals. Some dogs show a slow, insidious decline over months, with intermittent digestive upset and gradual weight loss. Others may appear relatively stable for long periods before experiencing sudden worsening, often accompanied by fluid retention or marked loss of body condition. Patterns of relapse and partial recovery are common, and the trajectory can be influenced by concurrent disease, changes in diet, or episodes of gastrointestinal inflammation.

Signals & patterns

Early signals

Soft or loose stools

Faeces may become less formed, sometimes pale or greasy in appearance, reflecting poor fat absorption. The pattern can be intermittent, with days or weeks of near-normal consistency followed by recurrence.

Weight loss with normal appetite

An owner may notice gradual loss of muscle or fat despite the dog eating normally or even more than usual. This reflects the body's inability to retain protein and calories that are leaking into the gut.

Reduced coat quality

The coat may lose its usual shine, appearing dull, dry, or brittle. This change often reflects deficiencies in fat-soluble nutrients and circulating proteins that support skin and hair structure.

Occasional vomiting

Some dogs bring up food or bile sporadically, particularly in the hours after eating. This can signal underlying inflammation or delayed gastric emptying associated with intestinal dysfunction.

Later signals

Fluid accumulation in the abdomen

As blood protein levels fall, fluid may leak from blood vessels into the abdominal cavity, creating visible swelling or a pot-bellied appearance. This occurs when the body can no longer maintain normal fluid balance.

Swelling in the limbs or face

Oedema—fluid gathering beneath the skin—can appear in the legs, around the eyes, or under the jaw. This is another consequence of low circulating protein, which normally holds fluid within blood vessels.

Breathing difficulty

In some cases, fluid may accumulate around the lungs or within the chest cavity, leading to increased respiratory effort or rapid, shallow breathing. This represents a more severe stage of protein loss and fluid imbalance.

Click to read about the biological mechanisms

How this is usually investigated

Investigation typically begins with a detailed history and physical examination, followed by blood tests that may reveal low protein levels and other biochemical changes. Because protein loss can arise from several different conditions, the process often involves a series of tests that progressively narrow the picture. Imaging, faecal analysis, and sometimes direct sampling of the intestinal lining help to distinguish intestinal lymphangiectasia from other causes of protein-losing enteropathy.

Blood biochemistry and haematology

Purpose: These tests measure serum albumin, globulins, and other proteins, and may reveal hypoalbuminaemia, hypoglobulinaemia, or low cholesterol. A complete blood count can show lymphopenia, a reduction in circulating lymphocytes that occurs when they are lost through the gut.
Considerations: Low protein levels confirm that protein is being lost, but they do not identify where the loss is occurring or what is causing it. Further tests are needed to distinguish intestinal loss from liver or kidney disease.

Faecal alpha-1 proteinase inhibitor

Purpose: This test measures a protein that is resistant to digestion and is lost in faeces when there is leakage from the intestinal lining. Elevated levels support the presence of protein-losing enteropathy.
Considerations: The test confirms intestinal protein loss but does not specify the underlying cause. It can be influenced by the timing of sample collection and recent dietary intake.

Abdominal ultrasonography

Purpose: Ultrasound examination of the abdomen can reveal thickened intestinal walls, dilated lacteals visible as hyperechoic striations in the mucosa, fluid accumulation in the abdomen, and changes in mesenteric lymph nodes. It provides a non-invasive view of structural changes within the gut.
Considerations: Ultrasonographic findings are suggestive but not definitive, and interpretation depends on the experience of the operator. Some animals with lymphangiectasia have normal ultrasound appearances, particularly early in the condition.

Intestinal biopsy

Purpose: Endoscopic or surgical biopsy allows direct examination of the intestinal lining under the microscope. Histopathology may show dilated lacteals, villous blunting, inflammation, or lipid accumulation within the mucosa, and can help distinguish primary lymphangiectasia from other inflammatory or neoplastic conditions.
Considerations: Biopsy requires anaesthesia and carries a small procedural risk. The abnormalities can be patchy, so a single biopsy may miss affected areas, and interpretation requires expertise in gastrointestinal pathology.

Imaging for concurrent disease

Purpose: Radiography or advanced imaging such as computed tomography may be used to assess for masses, lymph node enlargement, or other structural abnormalities that could obstruct lymphatic drainage or contribute to protein loss.
Considerations: These modalities are more useful when there is suspicion of a secondary cause of lymphatic obstruction. They add cost and may require sedation or general anaesthesia.

Options & trade-offs

Management of intestinal lymphangiectasia is usually a combination of dietary modification, medical treatment, and monitoring, tailored to the individual animal's response and the owner's circumstances. The goals are to reduce lymphatic pressure within the gut, replace lost nutrients, and manage inflammation where it is present. Different combinations suit different animals, and what works well in one case may be less effective or less practical in another.

Ultra-low-fat diet

Reducing dietary fat intake lowers the amount of chyle entering the lacteals, which can reduce lymphatic congestion and leakage. Commercial ultra-low-fat diets or home-prepared meals using lean protein sources and carbohydrates are used, often providing fat at less than 10–15% of calories. Fat-soluble vitamins and essential fatty acids may be supplemented in forms that bypass the lymphatic system.

Trade-offs: These diets can be less palatable, and some dogs refuse them or lose interest over time. Maintaining strict adherence requires careful label reading and consistency, and home-prepared diets require formulation to avoid nutritional imbalance.

Medium-chain triglyceride supplementation

Medium-chain triglycerides are fats that are absorbed directly into the bloodstream rather than through the lymphatic system, allowing some fat intake without increasing lymphatic load. They can be added to ultra-low-fat diets to improve palatability and provide additional calories.

Trade-offs: Some animals develop loose stools or poor tolerance when medium-chain triglycerides are introduced too quickly. They do not provide essential fatty acids, so additional supplementation may still be needed.

Corticosteroids or other immunosuppressive drugs

When intestinal inflammation is thought to contribute to lymphatic dysfunction or protein loss, corticosteroids such as prednisolone may be used to reduce mucosal inflammation and improve absorption. Other immunosuppressive agents may be considered in cases that do not respond well or where side effects from steroids are problematic.

Trade-offs: Corticosteroids can increase appetite, thirst, and urination, and long-term use carries risks including muscle wasting and increased susceptibility to infection. Response is variable, and some animals show little improvement with medical treatment alone.

Albumin or plasma transfusion

In animals with severe hypoalbuminaemia and marked fluid accumulation, transfusion of plasma or concentrated albumin can temporarily raise serum protein levels and reduce oedema or ascites. This provides time for other treatments to take effect.

Trade-offs: Transfusion is a short-term measure; the transfused protein will continue to leak into the gut unless the underlying process is addressed. It requires intravenous access, carries a risk of transfusion reactions, and may not be available in all settings.

Antibiotic therapy

Some animals with protein-losing enteropathy have concurrent small intestinal bacterial overgrowth or dysbiosis, which can worsen inflammation and nutrient malabsorption. Antibiotics such as metronidazole or tylosin are sometimes used for a defined period to address this.

Trade-offs: Response to antibiotics is inconsistent, and prolonged use can alter the gut microbiome in ways that may not be beneficial. This approach is more useful when there is clinical or laboratory evidence of bacterial involvement.

Common misconceptions

Misconception:

"A single negative test rules out intestinal lymphangiectasia."

Reality:

Lymphangiectasia can be patchy, and early or mild cases may not show obvious changes on ultrasound or even on biopsy if the affected area is not sampled. A normal result from one test does not exclude the condition, and the clinical picture often matters more than any single finding.

Misconception:

"Once protein levels return to normal, the diet can be relaxed or stopped."

Reality:

Intestinal lymphangiectasia is typically a chronic condition, and improvement in protein levels reflects control rather than cure. Reintroducing higher-fat foods or stopping dietary management often leads to relapse, and long-term adherence tends to be needed to maintain stability.

Misconception:

"All dogs with low albumin have the same underlying problem."

Reality:

Hypoalbuminaemia can arise from liver disease, kidney loss, poor production, or intestinal leakage, among other causes. The pattern of protein loss, presence or absence of other signs, and results from additional tests help to distinguish between these possibilities.

Related conditions

Protein-Losing Enteropathy

Intestinal lymphangiectasia is one of several causes of protein-losing enteropathy, the broader pattern in which protein leaks from the gut lining into the intestinal contents. Both share the hallmark features of low blood albumin, fluid accumulation, and diarrhoea, though protein-losing enteropathy can also arise from other forms of intestinal inflammation or damage.

Lymphoplasmacytic Enteritis

Lymphoplasmacytic enteritis can occur alongside intestinal lymphangiectasia, and in some cases the inflammation may contribute to lymphatic obstruction or leakage. Both conditions can present with chronic diarrhoea and weight loss, and distinguishing between them often requires biopsy of the intestinal wall.

Chylothorax

Chylothorax and intestinal lymphangiectasia both involve abnormalities in the lymphatic system, though in different parts of the body. In rare cases, an underlying disorder affecting lymphatic vessels throughout the body may contribute to both patterns, resulting in protein loss from the gut and accumulation of lymph-rich fluid in the chest.

Small Intestinal Bacterial Overgrowth

Small intestinal bacterial overgrowth can develop in dogs with intestinal lymphangiectasia, particularly when intestinal motility or local immune function is altered. Both conditions can cause chronic diarrhoea and malabsorption, and they may influence one another when present together.

Glomerulonephritis

Both intestinal lymphangiectasia and glomerulonephritis can result in protein loss from the body, though through different routes—one via the gut, the other through the kidneys. Severe protein loss from either condition can lead to low blood albumin, fluid accumulation, and similar clinical signs, and in some cases both may need to be considered when investigating unexplained hypoalbuminaemia.

Understanding how lymphatic dysfunction connects to other aspects of metabolic health can provide useful context, particularly when weight loss, nutrient deficiency, or fluid balance are ongoing concerns. Patterns of digestive upset, appetite, and energy levels over time can be helpful observations to have available during ongoing conversations. Many owners find it useful to track body condition, stool consistency, and response to dietary changes as part of the longer picture.